These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 18505967)

  • 1. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
    Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
    J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum 25-hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men.
    Layne TM; Weinstein SJ; Graubard BI; Ma X; Mayne ST; Albanes D
    Cancer; 2017 Jul; 123(14):2698-2704. PubMed ID: 28369777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.
    Albanes D; Mondul AM; Yu K; Parisi D; Horst RL; Virtamo J; Weinstein SJ
    Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1850-60. PubMed ID: 21784952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Travis RC; Crowe FL; Allen NE; Appleby PN; Roddam AW; Tjønneland A; Olsen A; Linseisen J; Kaaks R; Boeing H; Kröger J; Trichopoulou A; Dilis V; Trichopoulos D; Vineis P; Palli D; Tumino R; Sieri S; Bueno-de-Mesquita HB; van Duijnhoven FJ; Chirlaque MD; Barricarte A; Larrañaga N; González CA; Argüelles MV; Sánchez MJ; Stattin P; Hallmans G; Khaw KT; Bingham S; Rinaldi S; Slimani N; Jenab M; Riboli E; Key TJ
    Am J Epidemiol; 2009 May; 169(10):1223-32. PubMed ID: 19359375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk.
    Travis RC; Perez-Cornago A; Appleby PN; Albanes D; Joshu CE; Lutsey PL; Mondul AM; Platz EA; Weinstein SJ; Layne TM; Helzlsouer KJ; Visvanathan K; Palli D; Peeters PH; Bueno-de-Mesquita B; Trichopoulou A; Gunter MJ; Tsilidis KK; Sánchez MJ; Olsen A; Brenner H; Schöttker B; Perna L; Holleczek B; Knekt P; Rissanen H; Yeap BB; Flicker L; Almeida OP; Wong YYE; Chan JM; Giovannucci EL; Stampfer MJ; Ursin G; Gislefoss RE; Bjørge T; Meyer HE; Blomhoff R; Tsugane S; Sawada N; English DR; Eyles DW; Heath AK; Williamson EJ; Manjer J; Malm J; Almquist M; Marchand LL; Haiman CA; Wilkens LR; Schenk JM; Tangen CM; Black A; Cook MB; Huang WY; Ziegler RG; Martin RM; Hamdy FC; Donovan JL; Neal DE; Touvier M; Hercberg S; Galan P; Deschasaux M; Key TJ; Allen NE
    Cancer Res; 2019 Jan; 79(1):274-285. PubMed ID: 30425058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.
    Gilbert R; Metcalfe C; Fraser WD; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM
    Int J Cancer; 2012 Sep; 131(5):1187-96. PubMed ID: 22033893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study.
    Weinstein SJ; Yu K; Horst RL; Parisi D; Virtamo J; Albanes D
    PLoS One; 2011; 6(6):e20796. PubMed ID: 21695165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
    Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
    Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
    PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial.
    Stolzenberg-Solomon RZ; Hayes RB; Horst RL; Anderson KE; Hollis BW; Silverman DT
    Cancer Res; 2009 Feb; 69(4):1439-47. PubMed ID: 19208842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer.
    Weinstein SJ; Mondul AM; Kopp W; Rager H; Virtamo J; Albanes D
    Int J Cancer; 2013 Jun; 132(12):2940-7. PubMed ID: 23180681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.
    Platz EA; Leitzmann MF; Hollis BW; Willett WC; Giovannucci E
    Cancer Causes Control; 2004 Apr; 15(3):255-65. PubMed ID: 15090720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma 25-hydroxy vitamin D and subsequent prostate cancer risk in a nested Case-Control study in Japan: The JPHC study.
    Sawada N; Inoue M; Iwasaki M; Yamaji T; Shimazu T; Sasazuki S; Tsugane S
    Eur J Clin Nutr; 2017 Jan; 71(1):132-136. PubMed ID: 27759068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Weinstein SJ; Purdue MP; Smith-Warner SA; Mondul AM; Black A; Ahn J; Huang WY; Horst RL; Kopp W; Rager H; Ziegler RG; Albanes D
    Int J Cancer; 2015 Mar; 136(6):E654-64. PubMed ID: 25156182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum vitamin D and risk of bladder cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening trial.
    Mondul AM; Weinstein SJ; Horst RL; Purdue M; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1222-5. PubMed ID: 22623707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Leitzmann MF; Ahn J; Albanes D; Hsing AW; Schatzkin A; Chang SC; Huang WY; Weiss JM; Danforth KN; Grubb RL; Andriole GL;
    Cancer Causes Control; 2008 Dec; 19(10):1267-76. PubMed ID: 18618278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma 25-hydroxyvitamin D and prostate cancer risk: the multiethnic cohort.
    Park SY; Cooney RV; Wilkens LR; Murphy SP; Henderson BE; Kolonel LN
    Eur J Cancer; 2010 Mar; 46(5):932-6. PubMed ID: 20064705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum α-tocopherol and γ-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: a nested case-control study.
    Weinstein SJ; Peters U; Ahn J; Friesen MD; Riboli E; Hayes RB; Albanes D
    PLoS One; 2012; 7(7):e40204. PubMed ID: 22792240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Peters U; Leitzmann MF; Chatterjee N; Wang Y; Albanes D; Gelmann EP; Friesen MD; Riboli E; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):962-8. PubMed ID: 17507623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.
    Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M
    Br J Nutr; 2016 Jan; 115(2):305-14. PubMed ID: 26568368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.